Matches in Wikidata for { <http://www.wikidata.org/entity/Q80601793> ?p ?o ?g. }
- Q80601793 description "artículu científicu espublizáu en payares de 2004" @default.
- Q80601793 description "im November 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80601793 description "scientific article published on 01 November 2004" @default.
- Q80601793 description "wetenschappelijk artikel" @default.
- Q80601793 description "наукова стаття, опублікована в листопаді 2004" @default.
- Q80601793 name "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 name "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 type Item @default.
- Q80601793 label "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 label "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 prefLabel "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 prefLabel "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 P1433 Q80601793-636E6096-F28A-4918-A1DF-A21C3D46FC2C @default.
- Q80601793 P1476 Q80601793-84D2419E-299F-4E20-AA5B-AA6644471381 @default.
- Q80601793 P2093 Q80601793-0F8AE17C-0900-46F4-A6E8-10939D2861D4 @default.
- Q80601793 P2093 Q80601793-20640D6C-3A28-4796-AAAA-A6C43D9D34ED @default.
- Q80601793 P2093 Q80601793-2DD92685-3FAB-4742-95D2-1E9CFC48A1F0 @default.
- Q80601793 P2093 Q80601793-47404443-48EC-4860-927B-A5002962412D @default.
- Q80601793 P2093 Q80601793-5A0FC780-599C-4448-9827-B8547D0CEF5C @default.
- Q80601793 P2093 Q80601793-5BF45C98-758B-4C7F-A614-85CD21D85C80 @default.
- Q80601793 P2093 Q80601793-A6178BB8-44C4-47F1-A53D-F876A514B375 @default.
- Q80601793 P2093 Q80601793-B8051410-A0A6-42B0-9EA9-AA23FAA22BA5 @default.
- Q80601793 P2093 Q80601793-E2F89ABB-5B1D-4CE6-B19B-31EC051B2827 @default.
- Q80601793 P2093 Q80601793-FFF65820-7A51-4F82-B698-E40248C09E8A @default.
- Q80601793 P2860 Q80601793-045B6918-FE64-48D4-8061-A1797745DF9D @default.
- Q80601793 P2860 Q80601793-04CAA4E2-EA59-4DBC-923F-8C1786B1D61D @default.
- Q80601793 P2860 Q80601793-0AE9F3DA-9BC9-4A18-BEA4-9E989373A3F3 @default.
- Q80601793 P2860 Q80601793-14B2EFE2-495B-44C9-BAEC-5C696B81ED0C @default.
- Q80601793 P2860 Q80601793-1B595179-7B7F-4746-B8B1-9A89C564BE59 @default.
- Q80601793 P2860 Q80601793-22F4F841-F3E1-443B-BF69-DFF94E8189AE @default.
- Q80601793 P2860 Q80601793-24D3B2C1-5A5D-41F2-BAB3-0550944ACAEB @default.
- Q80601793 P2860 Q80601793-37671D6C-5610-497B-BE5D-A1E83806D1EF @default.
- Q80601793 P2860 Q80601793-3A23E5A9-89EB-44EB-A2F1-5A9A6981C599 @default.
- Q80601793 P2860 Q80601793-45539B06-6C8D-4DB9-8C50-6C79AC6E3F07 @default.
- Q80601793 P2860 Q80601793-4775EBB7-1D0B-41D6-8E51-AD49FEF9E39F @default.
- Q80601793 P2860 Q80601793-493AF422-6EFC-49A0-A884-7C0C5EFE2029 @default.
- Q80601793 P2860 Q80601793-4BEA49B7-8558-49C0-85EC-D81BB4932FAC @default.
- Q80601793 P2860 Q80601793-52E6537B-A239-4729-99B8-D26B6E3B787B @default.
- Q80601793 P2860 Q80601793-53A6B2DE-39DA-4533-9CA0-84A1B1546771 @default.
- Q80601793 P2860 Q80601793-62F3FFCC-A0D4-482C-B55B-BF8FDE60DE3E @default.
- Q80601793 P2860 Q80601793-659AB584-6881-4DC4-AFC1-649EC5AFA63D @default.
- Q80601793 P2860 Q80601793-65B2C2AE-5693-4382-8864-0E32A0B643FC @default.
- Q80601793 P2860 Q80601793-67EB3FA7-9739-4975-BC51-268D4948E4A7 @default.
- Q80601793 P2860 Q80601793-6F839E71-CDB0-491E-978F-67D933131C21 @default.
- Q80601793 P2860 Q80601793-85E74E71-56F2-414E-84A2-FF24EBA1F629 @default.
- Q80601793 P2860 Q80601793-A660CE32-C4D1-4A03-9312-0629EA986157 @default.
- Q80601793 P2860 Q80601793-A68A4B1C-D51C-41C3-86AB-E2969615922F @default.
- Q80601793 P2860 Q80601793-B783E4FE-F16D-483A-A8D9-1DEB5B35F83A @default.
- Q80601793 P2860 Q80601793-D49F25BC-41FD-4D0E-AD47-7D70E64C90BE @default.
- Q80601793 P2860 Q80601793-DD93487F-042A-40C7-8CCD-ED8AFB76CA5F @default.
- Q80601793 P2860 Q80601793-F6BA9485-32F6-40E8-8B46-17408BED8449 @default.
- Q80601793 P2860 Q80601793-FA45BF55-F863-4A0C-B09A-24C74960DF7A @default.
- Q80601793 P2860 Q80601793-FBB338C3-A90A-4994-90EC-5376AADF9DDA @default.
- Q80601793 P2860 Q80601793-FBB5D04D-6AEE-4D05-827A-6ACE8D8C475E @default.
- Q80601793 P2860 Q80601793-FC6F8B7C-1D22-4521-8E2E-DC9F8C0FC072 @default.
- Q80601793 P2888 Q80601793-E8A56DE9-5A42-4A85-B9BB-DEAA8ABD03B9 @default.
- Q80601793 P304 Q80601793-FAE3D642-4C5C-4E46-9957-4434A2257CAB @default.
- Q80601793 P31 Q80601793-5AAAEAAA-2209-41A0-866D-23236237DCAB @default.
- Q80601793 P356 Q80601793-46DF938F-2BC9-406C-9F92-F6B6CD86A181 @default.
- Q80601793 P433 Q80601793-0EBF0D3F-8E2E-44C4-89CE-D3EE4224AB47 @default.
- Q80601793 P478 Q80601793-AFEB7B5D-490D-4034-935A-D33D1D12B478 @default.
- Q80601793 P577 Q80601793-1FE94588-C9CF-4A29-BDFD-FEE2B1B2838E @default.
- Q80601793 P6179 Q80601793-217170AC-D61F-4EC2-A47B-DE4223764B54 @default.
- Q80601793 P698 Q80601793-4167E4D5-0430-4C0C-9DC4-AB19CF34074D @default.
- Q80601793 P921 Q80601793-F6A600A5-CE01-446A-A512-430A34EBD639 @default.
- Q80601793 P356 SJ.LEU.2403523 @default.
- Q80601793 P698 15385924 @default.
- Q80601793 P1433 Q6534498 @default.
- Q80601793 P1476 "Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse" @default.
- Q80601793 P2093 "Chi HS" @default.
- Q80601793 P2093 "Choi SJ" @default.
- Q80601793 P2093 "Kim S" @default.
- Q80601793 P2093 "Kim WK" @default.
- Q80601793 P2093 "Lee JH" @default.
- Q80601793 P2093 "Lee JS" @default.
- Q80601793 P2093 "Lee KH" @default.
- Q80601793 P2093 "Lee YS" @default.
- Q80601793 P2093 "Seol M" @default.
- Q80601793 P2860 Q29619924 @default.
- Q80601793 P2860 Q34095114 @default.
- Q80601793 P2860 Q40535464 @default.
- Q80601793 P2860 Q40558876 @default.
- Q80601793 P2860 Q40606402 @default.
- Q80601793 P2860 Q43943669 @default.
- Q80601793 P2860 Q47686713 @default.
- Q80601793 P2860 Q53652424 @default.
- Q80601793 P2860 Q54437663 @default.
- Q80601793 P2860 Q54684597 @default.
- Q80601793 P2860 Q57168094 @default.
- Q80601793 P2860 Q58959724 @default.
- Q80601793 P2860 Q61714676 @default.
- Q80601793 P2860 Q70235415 @default.
- Q80601793 P2860 Q70543533 @default.
- Q80601793 P2860 Q71360986 @default.
- Q80601793 P2860 Q73002127 @default.
- Q80601793 P2860 Q73117300 @default.
- Q80601793 P2860 Q73348822 @default.
- Q80601793 P2860 Q73383048 @default.
- Q80601793 P2860 Q74082697 @default.
- Q80601793 P2860 Q74249659 @default.